These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 37814811)
1. PHD3 inhibits colon cancer cell metastasis through the occludin-p38 pathway. Li Y; Yuan T; Zhang H; Liu S; Lun J; Guo J; Wang Y; Zhang Y; Fang J Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1749-1757. PubMed ID: 37814811 [TBL] [Abstract][Full Text] [Related]
2. Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner. Xu Y; Gao Q; Xue Y; Li X; Xu L; Li C; Qin Y; Fang J J Biol Chem; 2019 Jun; 294(25):9949-9958. PubMed ID: 31092600 [TBL] [Abstract][Full Text] [Related]
3. PHD3 inhibits cell proliferation through hydroxylation of PAX2 at proline 9. Lun J; Wang Y; Gao Q; Wang Y; Zhang H; Fang J Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(5):708-715. PubMed ID: 35920196 [TBL] [Abstract][Full Text] [Related]
4. PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function. Chen Y; Zhang HS; Fong GH; Xi QL; Wu GH; Bai CG; Ling ZQ; Fan L; Xu YM; Qin YQ; Yuan TL; Sun H; Fang J J Biol Chem; 2015 Aug; 290(33):20580-9. PubMed ID: 26124271 [TBL] [Abstract][Full Text] [Related]
5. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Xue J; Li X; Jiao S; Wei Y; Wu G; Fang J Gastroenterology; 2010 Feb; 138(2):606-15. PubMed ID: 19786027 [TBL] [Abstract][Full Text] [Related]
6. Prolyl hydroxylase 3 controls the intestine goblet cell generation through stabilizing ATOH1. Xu YM; Gao Q; Zhang JZ; Lu YT; Xing DM; Qin YQ; Fang J Cell Death Differ; 2020 Jul; 27(7):2131-2142. PubMed ID: 31959916 [TBL] [Abstract][Full Text] [Related]
7. Melatonin inhibits colon cancer RKO cell migration by downregulating Rho‑associated protein kinase expression via the p38/MAPK signaling pathway. Liu Z; Zou D; Yang X; Xue X; Zuo L; Zhou Q; Hu R; Wang Y Mol Med Rep; 2017 Dec; 16(6):9383-9392. PubMed ID: 29152648 [TBL] [Abstract][Full Text] [Related]
8. Prolyl-4-hydroxylase 3 (PHD3) expression is downregulated during epithelial-to-mesenchymal transition. Place TL; Nauseef JT; Peterson MK; Henry MD; Mezhir JJ; Domann FE PLoS One; 2013; 8(12):e83021. PubMed ID: 24367580 [TBL] [Abstract][Full Text] [Related]
9. Deletion of prolyl hydroxylase domain-containing enzyme 3 (phd3) in zebrafish facilitates hypoxia tolerance. Liao Q; Deng H; Wang Z; Yu G; Zhu C; Jia S; Liu W; Bai Y; Sun X; Chen X; Xiao W; Liu X J Biol Chem; 2023 Dec; 299(12):105420. PubMed ID: 37923141 [TBL] [Abstract][Full Text] [Related]
10. Regulation of the ring finger E3 ligase Siah2 by p38 MAPK. Khurana A; Nakayama K; Williams S; Davis RJ; Mustelin T; Ronai Z J Biol Chem; 2006 Nov; 281(46):35316-26. PubMed ID: 17003045 [TBL] [Abstract][Full Text] [Related]
11. Prolyl Hydroxylase 3 Attenuates MCL-1-Mediated ATP Production to Suppress the Metastatic Potential of Colorectal Cancer Cells. Radhakrishnan P; Ruh N; Harnoss JM; Kiss J; Mollenhauer M; Scherr AL; Platzer LK; Schmidt T; Podar K; Opferman JT; Weitz J; Schulze-Bergkamen H; Koehler BC; Ulrich A; Schneider M Cancer Res; 2016 Apr; 76(8):2219-30. PubMed ID: 26921340 [TBL] [Abstract][Full Text] [Related]
12. Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell. Jia ZC; Wan YL; Tang JQ; Dai Y; Liu YC; Wang X; Zhu J Int J Colorectal Dis; 2012 Apr; 27(4):437-45. PubMed ID: 22076613 [TBL] [Abstract][Full Text] [Related]
13. Calcium oxalate crystals induces tight junction disruption in distal renal tubular epithelial cells by activating ROS/Akt/p38 MAPK signaling pathway. Yu L; Gan X; Liu X; An R Ren Fail; 2017 Nov; 39(1):440-451. PubMed ID: 28335665 [TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK. Nishihara H; Hwang M; Kizaka-Kondoh S; Eckmann L; Insel PA J Biol Chem; 2004 Jun; 279(25):26176-83. PubMed ID: 15078890 [TBL] [Abstract][Full Text] [Related]
15. Prolyl Hydroxylase 3 Knockdown Accelerates Zacharias NM; Wang L; Maity T; Li L; Millward SW; Karam JA; Wood CG; Navai N Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799686 [TBL] [Abstract][Full Text] [Related]
17. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis. Xie L; Pi X; Wang Z; He J; Willis MS; Patterson C J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836 [TBL] [Abstract][Full Text] [Related]
18. Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through the TGF-β/Smad signaling pathway. Zhou H; Zou J; Shao C; Zhou A; Yu J; Chen S; Xu C Pathol Res Pract; 2022 Feb; 230():153749. PubMed ID: 34959098 [TBL] [Abstract][Full Text] [Related]
19. Prolyl hydroxylase 3 (PHD3) expression augments the development of regulatory T cells. Singh Y; Shi X; Zhang S; Umbach AT; Chen H; Salker MS; Lang F Mol Immunol; 2016 Aug; 76():7-12. PubMed ID: 27331863 [TBL] [Abstract][Full Text] [Related]
20. Prolyl hydroxylase 3 overexpression accelerates the progression of atherosclerosis in ApoE-/- mice. Liu H; Xia Y; Li B; Pan J; Lv M; Wang X; An F Biochem Biophys Res Commun; 2016 Apr; 473(1):99-106. PubMed ID: 26995088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]